Company: LGN
Filing Date: 2025-09-02
Form Type: S-1/A
Source: 0001193125-25-193346
Chunk: 100

Company: Legence Corp.
Filing Date: 2025-09-02
Form: S-1/A
Chunk 100
---
 us based upon the assumed public offering price of $27.00 per share of Class A Common Stock (the midpoint
of the price range set forth on the cover page of this prospectus), after deducting underwriting discounts and commissions and estimated offering expenses payable by us.

We intend to contribute all of the net proceeds from this offering (not including the exercise of the underwriters’ option to purchase
additional shares) to Legence Holdings in exchange for LGN Units. Legence Holdings intends to use such net proceeds from this offering for the repayment of outstanding borrowings under our Term Loan Credit Facility and the remaining proceeds for
general corporate purposes.

If the underwriters exercise their option to purchase additional shares of Class A Common Stock in full,
the additional net proceeds to us will be approximately $80.6 million (based on an assumed initial offering price of $27.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus), after deducting
underwriting discounts and commissions. We intend to contribute the $80.6 million of net proceeds received by us from the exercise of the option to Legence Holdings, in exchange for additional LGN Units being issued to Legence Sub. Legence Holdings
will use (i) approximately $30.8 million of such net proceeds to purchase LGN Units, together with an equal number of shares of Class B Common Stock, from Legence Parent at a purchase price per LGN Unit and share of Class B Common Stock equal to the
public offering price per share of Class A Common Stock in this offering, net of underwriting discounts and commissions and (ii) approximately $49.8 million of such net proceeds to repay additional outstanding borrowings under the Term Loan
Credit Facility.

We will not receive any proceeds from the sale of additional shares of Class A Common Stock by the selling
stockholder. We will, however, bear the costs associated with the sale of additional shares of Class A Common Stock by the selling stockholder, other than underwriting discounts and commissions. For more information, see “Principal and Selling
Stockholders” and “Underwriting (Conflicts of Interest).”

As of June 30, 2025 and December 31, 2024, we had an
outstanding principal balance of approximately $1,582.1 million and $1,590.4 million, respectively, under the Term Loan Credit Facility. The Term Loan Credit Facility matures on December 16, 2028. Legence Holdings